References
- Reubi J. C., Waser B., van Hagen M., Lamberts S. W. J., Krenning E. P., Gebbers J. O, Laissue J. A. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 1992; 50: 895–900
- Vanhagen P. M., Krenning E. P., Reubi J. C., Mulder A. H., Bakker W. H., Oei H. Y., Löwenberg B., Lamberts S. W.J. Somatostatin analogue scintigraphy of malignant lymphomas. Brit J Haematol 1993; 83: 75–79
- Krenning E. P., Bakker W. H., Breeman W. A. P., Koper J. W., Kooij P. P. M., Ausema L., Lameris J. S., Reubi J. C., Lamberts S. W.J. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1989; 1: 242–244
- Krenning E. P., Bakker W. H., Kooij P. P. M., Breeman W. A. P., Oei H. Y., de Jong M., Reubi J. C., Visser T. J., Bruns C., Kwekkeboom D. J., Reijs A. E. M., van Hagen P. M., Koper J. W., Lamberts S. W.J. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide in man: metabolism, dosimetry and comparison with [123I-Tyr3]-octreotide. J Nucl Med 1992; 33: 652–658
- Bares R., Galonska P., Dempke W., Handt S., Bull U., Osieka R. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Horm Metab Res 1993; Suppl 27: 56–58
- Bong S. B., VanderLaan J. G., Louwes H., Schuurman J. J. Clinical experience with somatostatin receptor imaging in lymphoma. Semin Oncol 1994; 21, Suppl 13: 46–50
- Stoffel M., Jamar F., Martiat P., Leners N., Beckers C., Ferrant A., Pauwels S. Somatostatin receptor imaging in lymphomas (abstract). J Nucl Med 1994; 35: 131P
- Wiseman G. A., Witzig T. E., Mullan B. P. Imaging of Hodgkin's disease and non-Hodgkin's lymphoma with indium In-111 pentetreotide (abstract). J Nucl Med 1994; 35: 132P
- van den Anker-Lugtenburg P. J., Krenning E. P., Oei H. Y., Gerrits C. J. H., Vanhagen P. M., Reubi J. C, Lamberts S. W. J., Löwenberg B. The role of somatostatin receptor scintigraphy (SRS) in the initial staging of malignant lymphoma (abstract). J Nucl Med 1994; 35: 132P
- Lipp R. W., Silly H., Ranner G., Dobnig H., Passath A., Leb G., Krejs G. J. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med 1995; 36: 13–18
- Sarda L., Duet M., Zini J. M., Berolatti B., Benelhadj S., Tobelem G., Mundler O. Indium-111 pentetreotide scintigraphy in malignant lymphomas. Eur J Nucl Med 1995; 22: 1105–1109
- Goldsmith S. J., Macapinlac H. A., O'Brien J. P. Somatostatin-receptor imaging in lymphoma. Semin Nucl Med 1995; 25: 262–271
- Ivančeví V., Nauck C., Wörmann B., Sandrock D., Hiddemann W., Munz D. L., Emrich D. Somatostatin receptor scintigraphy in Hodgkin-(HL) and non-Hodgkin lymphomas (NHL) (abstract). J Nucl Med 1994; 35: 132P
- Lennert K., Feller A. C. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification). Springer, Berlin Heidelbarg New York 1992
- Luig H., Eschner W., Bähre M., Voth E., Nolte G. An iterative strategy for determination of the source distribution in single-photon emission tomography with a rotating gamma camera (SPECT). Nucl-Med 1988; 27: 140–146
- Nauck C., Ivančeví V., Emrich D., Creutzfeldt W. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-enteropancreatic tumors. Z Gastroenterol 1994; 32: 323–327
- Spremulli E., Dexter D. L. Human tumor cell heterogeneity and metastases. J Clin Oncol 1983; 1: 496–509
- Schnipper L. E. Clinical implications of tumor cell heterogeneity. N Engl Med J 1986; 314: 1423–1431
- Feller A. C. Pathologische Anatomie und Immunhistologie der Non-Hodgkin-Lymphome. Internist 1993; 34: 106–113